MR-proADM as a Early Biomarker for DGF and AR in Kidney and Liver Transplantation
Abroad (travel likely)Recruiting
Conditions
Kidney Transplant; Complications · Liver Transplant; Complications
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Rome Tor Vergata, Rome, Italy
Study leads
Roberta Angelico, PhD FEBS
Principal Investigator
University of Rome Tor Vergata